title: D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients.
authors.forename: T P
authors.initials: TP
authors.lastname: Su
authors.forename: A K
authors.initials: AK
authors.lastname: Malhotra
authors.forename: K
authors.initials: K
authors.lastname: Hadd
authors.forename: A
authors.initials: A
authors.lastname: Breier
authors.forename: D
authors.initials: D
authors.lastname: Pickar
mesh_terms: D000328:Adult; D001549:Benzamides; D003024:Clozapine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D018967:Risperidone / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D001549:Benzamides; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; D003024:Clozapine; D018967:Risperidone